Komori
SRE Holdings (2980) · InitiativeAdvanced

Investment in new product development in adjacent fields, including healthcare DX

First written in FY2024-Q1. 11 of 12 entries say "Advanced", first in FY2024-Q2. Latest entry: 2026-11-11.

12entries
4years
6from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2024-Q2 – 2026-11-112023: 220232024: 220242025: 120252026: 72026
Same theme, other companies
IT, Out-of-Pocket Revenue and Preventive Care Product and Service DevelopmentA theme 3 companies write about · 0 as a headwind · 3 as a tailwind

2 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「At these healthcare-related facilities, the company is establishing a structure to improve the accuracy of utilization forecasts and continuously improve operating efficiency by incorporating into operations industry-specific AI developed and operated by the AI Cloud & Consulting segment.」

    The company has progressed to the stage of incorporating industry-specific AI into healthcare facility operations and applying it to utilization forecasting and operating efficiency improvements.
  2. FY2026-H1AdvancedAnnual report

    「Life & Healthcare Solutions (LH, which provides operational cloud tools and DX solutions primarily for the healthcare, IT and financial sectors) benefited from the revenue contribution of Medix Inc., which became a subsidiary in April 2024, as well as steady growth in customer acquisition. From the third quarter onward, the company has been pursuing expansion into large-scale medical and welfare facilities, while also advancing multiple new product and new feature development projects, mainly in the healthcare sector.」

    In addition to the revenue contribution from Medix Inc. and progress in customer acquisition, the company is pursuing expansion into large-scale medical and welfare facilities from the third quarter onward, along with the development of multiple new products and features.
  3. FY2025-H1AdvancedAnnual report

    「Specifically, in healthcare, in addition to making Medix Inc. a subsidiary in April 2024 to provide cloud-based electronic medical billing systems and claims-processing support for medical clinics, the company signed a contract during the current second quarter with a large corporate entity operating multiple facilities, contributing to an increase in the number of contracted companies. It also began field testing of telemedicine using life-log data through a collaboration with Paramount Bed Co., Ltd. and launched integration with the cloud services of Mizuho Bank, Ltd.」

    Healthcare DX has progressed through the acquisition of Medix Inc. as a subsidiary, large corporate contracts, field testing of telemedicine, and cloud integration with Mizuho Bank.
  4. FY2024-Q3AdvancedAnnual report

    「In the healthcare sector, the company also developed prototypes of DX solutions addressing clinic management issues such as patient acquisition and nurturing, steadily progressing efforts to secure revenue and accumulate product feedback. As a result, revenue in the Other segment for the nine months ended the third quarter was ¥53.127 million, generated through the operation of the healthcare business, while the segment loss was ¥137.444 million due to investment in new product development.」

    After establishing a structure with physicians and medical office staff, the company proceeded with prototype development and operations for DX solutions addressing clinic management issues, recording revenue of ¥53.127 million, while posting a segment loss of ¥137.444 million due to investment in new product development.
  5. FY2024-Q2AdvancedAnnual report

    「In addition, as an initiative in an adjacent field, the company established a prototype development structure with physicians and medical office staff and developed a prototype DX solution addressing clinic management issues such as patient acquisition and lead nurturing.」

    For healthcare DX, the company established a development structure with physicians and medical office staff and advanced development through prototypes addressing clinic management issues.
  6. FY2024-Q1First statedAnnual report

    「In this segment, the company is investing in the development of new products, including healthcare DX, to achieve sustainable growth over the medium to long term, mainly through prototype development and talent acquisition. It is also operating a healthcare business for product development and accelerating initiatives to create “highly practical technology incorporating real-world operations.”」

    In the newly established Other segment, the company is advancing prototype development, talent acquisition and healthcare business operations for new products, including healthcare DX.
Moved together

"Developing customers for AI cloud services and AI consulting" moved the same way as this thread, in the same document, in 10 of its 12 moves.

1076666★123456
  1. ★This thread
  2. 1Developing customers for AI cloud services and AI consulting10×
  3. 2Raising Working Capital and Business Funding through Bank Borrowings7×
  4. 3Business Supplementation and Growth Acceleration through M&A and Business Alliances6×
  5. 4Revenue underpinned by monthly subscription-based AI cloud services6×
  6. 5Creation of a vertical generative AI model trained on proprietary primary data6×
  7. 6Off-Balance-Sheet Treatment and Expansion of the Asset Management Business6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
SRE Holdings's next results are scheduled for 2026-11-11. Read the earnings preview It last moved in the Earnings presentation of 2026-11-11: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.